Japan gets Certara's D360 to boost drug discovery

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Aug, 2014

Singapore: Certara, a drug development and drug safety consultancy firm has launched its D360 software in Japan for prov...Read more

3SBio to develop antibody for acute leukemia

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Aug, 2014

Singapore: Chinese biotechnology firm, 3SBio, has signed an exclusive license with Korean firm, DiNonA  for the develop...Read more

Aussie firm initiates bronchitis drug trial for smokers

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2013

Singapore: Australia-based clinical-stage drug development company, Invion, initiated and commenced patient enrolment in...Read more

Breast cancer boasts of highest drug pipeline'

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Sep, 2014

Singapore: Breast cancer therapeutics pipeline has higher innovation in first-in-class molecules, with many new technolo...Read more

Ascend to begin PhII trial for skin cancer

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Sep, 2014

Singapore: Ascend Biopharmaceuticals, a Melbourne-based immunotherapy company, plans to begin a Phase 2 clinical trial o...Read more

Singapore firm progresses on urinary tract infections drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jan, 2015

Singapore: Singapore's biopharmaceutical company, MerLion Pharmaceuticals, has recieved positive results from a phase 2 ...Read more

US investment firm expands in China

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jan, 2015

Singapore: Ally Bridge Group (ABG), a global healthcare-focused investment platform, has expanded its global biopharmace...Read more

Aspirin may reduce ovarian cancer risk: NIH

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 1 Comment | 07 Feb, 2014

Singapore: Women who take aspirin daily may reduce their risk of ovarian cancer by 20 percent, according to a study by s...Read more

Zebrafish genes linked to human respiratory diseases'

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Sep, 2014

Singapore: A small freshwater fish found in many tropical aquariums may hold the key to unlocking one of the leading cau...Read more

FDA to further review Otsuka kidney drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Sep, 2013

Singapore: Otsuka Pharmaceutical received a Complete Response Letter (CRL) from the US FDA regarding the new drug applic...Read more

Satish Jindal, BMS India R&D head, to lead US innovation venture

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2014

Singapore: Allied-Bristol Life Sciences, a jointly owned enterprise between Allied Minds and Bristol-Myers Squibb, has a...Read more

US firm discovers potential biomarker for malaria

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Nov, 2014

Singapore: US based biotech firm, Genocea Biosciences, has identified a cluster of antigens, generated using its ATLAS a...Read more

Malaria drug may cure asthma: Research

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Aug, 2014

Singapore: National University of Singapore has demonstrated effectiveness of artesunate, a common herbal-based anti-mal...Read more

Danish firm, Aussie instiute to co-develop pathological drugs

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Nov, 2013

Singapore: Danish firm, Mirrx Therapeutics and Australia's Centenary Institute of Cancer Medicine and Cell Biology has f...Read more

Dainippon sets up cancer drug subsidiary in the US

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Oct, 2013

Singapore: Japan-based Dainippon Sumitomo Pharma (DSP), has decided to establish an anti-cancer drugs sales company in t...Read more

Japanese, Korean firm to jointly develop breast cancer drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jan, 2015

Singapore: Japanese company, Kyowa Hakko Kirin and Korean firm, Syndax Pharmaceuticals, have entered into a license agre...Read more

Novogen's chemotherapeutic agent set to enter human trial in 2015

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 Dec, 2014

Singapore: Cantrixil, a first-in-class experimental chemotherapeutic, developed by Australia/US-based biotech firm Novog...Read more

Auspherix raises $1 mn for antibiotics

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 23 Oct, 2014

Singapore: Auspherix, an early stage anti-infectives company developing novel antibiotics to treat resistant bacterial d...Read more